Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01801371 : 68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma
PhaseEarly Phase 1
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Males and females, =18 years old;

- In suspicion of brain glioma on MRI;

- The tumor will be surgically removed and histological diagnosis will be available.

Exclusion Criteria:

- Females planning to bear a child recently or with childbearing potential;

- Known severe allergy or hypersensitivity to IV radiographic contrast;

- Inability to lie still for the entire imaging time because of cough, pain, etc.

- Inability to complete the needed examinations due to severe claustrophobia, radiation
phobia, etc.

- Concurrent severe and/or uncontrolled and/or unstable other medical disease that, in
the opinion of the investigator, may significantly interfere with study compliance.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01801371      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740